PN HESI Pharmacology Exam Prep Document | 2026/2027
Edition | 200 Verified Questions
PN HESI Pharmacology Exam 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100% Verified
Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive review guide is meticulously crafted for nursing students preparing for the PN
HESI Pharmacology exam. It contains 200 verified questions with correct answers and detailed
rationales, covering essential pharmacological concepts, drug classifications, and nursing interventions.
The content is aligned with the latest Evolve HESI PN Pharmacology test blueprint, ensuring
high-yield, exam-focused preparation. Each question is designed to reinforce critical thinking and
clinical application, making this an indispensable resource for achieving a passing score.
Key Features:
Pharmacokinetics and pharmacodynamics
Drug classifications and mechanisms of action
Nursing considerations and patient education
Adverse effects, contraindications, and interactions
Dosage calculations and medication administration
Legal and ethical aspects of pharmacology
Updates for 2026:
- Updated to reflect the 2026/2027 HESI PN Pharmacology test plan
- Incorporated latest evidence-based practice guidelines
- Revised rationales to enhance clarity and depth
- Added new questions on emerging drug therapies
- Aligned with current NCLEX-PN and HESI exam formats
Abstract:
This exam preparation document is a definitive resource for nursing candidates targeting the PN HESI
Pharmacology examination. It comprises 200 meticulously selected questions that mirror the content and difficulty
of the actual exam. Each question is accompanied by a correct answer and a comprehensive rationale that explains
not only why the correct choice is right but also why the distractors are incorrect, thereby deepening the learner's
understanding of pharmacological principles. The material is organized to systematically cover all major drug
categories, including antibiotics, cardiovascular agents, psychotropics, and endocrine therapies, with an emphasis
on nursing implications, patient safety, and clinical decision-making. Updated for the 2026/2027 academic year,
this guide integrates the latest guidelines and reflects current best practices in pharmacology education. It serves
as an essential tool for self-assessment, targeted review, and confidence building, ultimately empowering students
to excel on their examination and in clinical practice.
Keywords:
PN HESI Pharmacology, HESI PN review, Pharmacology test bank, Nursing exam prep, Drug rationales,
2026/2027 nursing, Evolve HESI
Answer Format:
Each question is presented in a multiple-choice format with four options. The correct answer is clearly indicated,
followed by a detailed rationale that explains the underlying pharmacological principle. Additionally, each
rationale includes an explanation of why the incorrect options are not the best choices, enhancing critical thinking
and comprehension.
Compliance Checklist:
Page 1
, Aligned with the latest HESI PN Pharmacology test blueprint
Includes 200 verified questions with correct answers and rationales
Updated for the 2026/2027 academic year
Covers all major content areas as per Evolve guidelines
Suitable for self-study and exam review
Content Area Overview:
Content Area Questions Key Topics Weight
Pharmacokinetics and 1-25 Absorption, distribution, metabolism, 12.5%
Pharmacodynamics excretion, receptor theory, dose-response
Drug Classifications and 26-75 Antibiotics, analgesics, cardiovascular, 25%
Mechanisms CNS, endocrine, respiratory
Nursing Considerations and 76-120 Administration routes, monitoring, side 22.5%
Patient Education effects, teaching points
Adverse Effects, 121-160 Toxicities, allergic reactions, drug-drug 20%
Contraindications, and interactions, food interactions
Interactions
Dosage Calculations and 161-180 Metric conversions, IV flow rates, pediatric 10%
Medication Administration doses, safe dose ranges
Legal and Ethical Aspects 181-200 Controlled substances, medication errors, 10%
patient rights, documentation
Page 2
,Q1. A patient with a history of hypertension and type 2 diabetes is initiated on
lisinopril. Which laboratory value warrants immediate follow-up before the next
dose?
A. Serum potassium 5.8 mEq/L
B. Serum creatinine 1.1 mg/dL
C. Fasting blood glucose 110 mg/dL
D. Hemoglobin A1c 7.2%
Correct Answer: A. Serum potassium 5.8 mEq/L
Rationale: ACE inhibitors like lisinopril can cause hyperkalemia due to reduced
aldosterone. A potassium of 5.8 mEq/L exceeds the upper limit (3.5-5.0) and poses a risk
of cardiac arrhythmias. The other values are within acceptable ranges or not directly
impacted acutely.
Why Wrong:
B - A creatinine of 1.1 mg/dL is within normal limits and does not require immediate
action.
C - Fasting glucose of 110 mg/dL is slightly elevated but not an acute concern for
lisinopril.
D - Hemoglobin A1c of 7.2% reflects long-term glucose control, not an immediate
effect of lisinopril.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 24
Q2. Which drug-drug interaction mechanism best explains the reduced efficacy of
oral contraceptives when co-administered with carbamazepine?
A. Inhibition of CYP3A4 leading to increased estrogen levels
B. Induction of CYP3A4 leading to increased estrogen metabolism
C. Competitive antagonism at estrogen receptors
D. Enhanced renal clearance of ethinyl estradiol
Correct Answer: B. Induction of CYP3A4 leading to increased estrogen metabolism
Rationale: Carbamazepine is a potent CYP3A4 inducer, which accelerates the metabolism
of ethinyl estradiol, reducing its plasma concentration and contraceptive efficacy. This is a
classic enzyme induction interaction.
Why Wrong:
A - Inhibition of CYP3A4 would increase estrogen levels, not reduce efficacy.
C - Carbamazepine does not act as a receptor antagonist for estrogen.
D - Renal clearance is not the primary pathway for ethinyl estradiol metabolism.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 4
Page 3
, Q3. A patient is receiving gentamicin IV for a severe infection. Which assessment
finding indicates an adverse effect that may necessitate a change in therapy?
A. Bilateral tinnitus and dizziness
B. Elevated blood pressure
C. Increased urine output
D. Mild headache
Correct Answer: A. Bilateral tinnitus and dizziness
Rationale: Gentamicin is an aminoglycoside that can cause ototoxicity (both cochlear and
vestibular). Tinnitus and dizziness are early signs of vestibular damage. The other findings
are not typical of gentamicin toxicity.
Why Wrong:
B - Hypertension is not a common adverse effect of gentamicin.
C - Increased urine output is not an expected effect; gentamicin may cause
nephrotoxicity, which usually reduces output.
D - Headache is not a characteristic sign of gentamicin toxicity.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 82
Q4. A patient with chronic obstructive pulmonary disease (COPD) is prescribed
tiotropium. Which statement best describes the mechanism of action of this
medication?
A. Selective beta-2 agonist that relaxes bronchial smooth muscle
B. Long-acting muscarinic antagonist that inhibits bronchoconstriction
C. Corticosteroid that reduces airway inflammation
D. Leukotriene receptor antagonist that decreases mucus production
Correct Answer: B. Long-acting muscarinic antagonist that inhibits
bronchoconstriction
Rationale: Tiotropium is a long-acting muscarinic antagonist (LAMA) that blocks
acetylcholine at M3 receptors, reducing bronchoconstriction and mucus secretion. It is not
a beta-agonist, corticosteroid, or leukotriene modifier.
Why Wrong:
A - Beta-2 agonists are a different class (e.g., albuterol, salmeterol).
C - Corticosteroids act via anti-inflammatory pathways, not directly on muscarinic
receptors.
D - Leukotriene receptor antagonists are used primarily in asthma, not COPD.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 71
Q5. A patient on warfarin has an INR of 5.2. Which agent is most appropriate for
immediate reversal?
Page 4
Edition | 200 Verified Questions
PN HESI Pharmacology Exam 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100% Verified
Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive review guide is meticulously crafted for nursing students preparing for the PN
HESI Pharmacology exam. It contains 200 verified questions with correct answers and detailed
rationales, covering essential pharmacological concepts, drug classifications, and nursing interventions.
The content is aligned with the latest Evolve HESI PN Pharmacology test blueprint, ensuring
high-yield, exam-focused preparation. Each question is designed to reinforce critical thinking and
clinical application, making this an indispensable resource for achieving a passing score.
Key Features:
Pharmacokinetics and pharmacodynamics
Drug classifications and mechanisms of action
Nursing considerations and patient education
Adverse effects, contraindications, and interactions
Dosage calculations and medication administration
Legal and ethical aspects of pharmacology
Updates for 2026:
- Updated to reflect the 2026/2027 HESI PN Pharmacology test plan
- Incorporated latest evidence-based practice guidelines
- Revised rationales to enhance clarity and depth
- Added new questions on emerging drug therapies
- Aligned with current NCLEX-PN and HESI exam formats
Abstract:
This exam preparation document is a definitive resource for nursing candidates targeting the PN HESI
Pharmacology examination. It comprises 200 meticulously selected questions that mirror the content and difficulty
of the actual exam. Each question is accompanied by a correct answer and a comprehensive rationale that explains
not only why the correct choice is right but also why the distractors are incorrect, thereby deepening the learner's
understanding of pharmacological principles. The material is organized to systematically cover all major drug
categories, including antibiotics, cardiovascular agents, psychotropics, and endocrine therapies, with an emphasis
on nursing implications, patient safety, and clinical decision-making. Updated for the 2026/2027 academic year,
this guide integrates the latest guidelines and reflects current best practices in pharmacology education. It serves
as an essential tool for self-assessment, targeted review, and confidence building, ultimately empowering students
to excel on their examination and in clinical practice.
Keywords:
PN HESI Pharmacology, HESI PN review, Pharmacology test bank, Nursing exam prep, Drug rationales,
2026/2027 nursing, Evolve HESI
Answer Format:
Each question is presented in a multiple-choice format with four options. The correct answer is clearly indicated,
followed by a detailed rationale that explains the underlying pharmacological principle. Additionally, each
rationale includes an explanation of why the incorrect options are not the best choices, enhancing critical thinking
and comprehension.
Compliance Checklist:
Page 1
, Aligned with the latest HESI PN Pharmacology test blueprint
Includes 200 verified questions with correct answers and rationales
Updated for the 2026/2027 academic year
Covers all major content areas as per Evolve guidelines
Suitable for self-study and exam review
Content Area Overview:
Content Area Questions Key Topics Weight
Pharmacokinetics and 1-25 Absorption, distribution, metabolism, 12.5%
Pharmacodynamics excretion, receptor theory, dose-response
Drug Classifications and 26-75 Antibiotics, analgesics, cardiovascular, 25%
Mechanisms CNS, endocrine, respiratory
Nursing Considerations and 76-120 Administration routes, monitoring, side 22.5%
Patient Education effects, teaching points
Adverse Effects, 121-160 Toxicities, allergic reactions, drug-drug 20%
Contraindications, and interactions, food interactions
Interactions
Dosage Calculations and 161-180 Metric conversions, IV flow rates, pediatric 10%
Medication Administration doses, safe dose ranges
Legal and Ethical Aspects 181-200 Controlled substances, medication errors, 10%
patient rights, documentation
Page 2
,Q1. A patient with a history of hypertension and type 2 diabetes is initiated on
lisinopril. Which laboratory value warrants immediate follow-up before the next
dose?
A. Serum potassium 5.8 mEq/L
B. Serum creatinine 1.1 mg/dL
C. Fasting blood glucose 110 mg/dL
D. Hemoglobin A1c 7.2%
Correct Answer: A. Serum potassium 5.8 mEq/L
Rationale: ACE inhibitors like lisinopril can cause hyperkalemia due to reduced
aldosterone. A potassium of 5.8 mEq/L exceeds the upper limit (3.5-5.0) and poses a risk
of cardiac arrhythmias. The other values are within acceptable ranges or not directly
impacted acutely.
Why Wrong:
B - A creatinine of 1.1 mg/dL is within normal limits and does not require immediate
action.
C - Fasting glucose of 110 mg/dL is slightly elevated but not an acute concern for
lisinopril.
D - Hemoglobin A1c of 7.2% reflects long-term glucose control, not an immediate
effect of lisinopril.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 24
Q2. Which drug-drug interaction mechanism best explains the reduced efficacy of
oral contraceptives when co-administered with carbamazepine?
A. Inhibition of CYP3A4 leading to increased estrogen levels
B. Induction of CYP3A4 leading to increased estrogen metabolism
C. Competitive antagonism at estrogen receptors
D. Enhanced renal clearance of ethinyl estradiol
Correct Answer: B. Induction of CYP3A4 leading to increased estrogen metabolism
Rationale: Carbamazepine is a potent CYP3A4 inducer, which accelerates the metabolism
of ethinyl estradiol, reducing its plasma concentration and contraceptive efficacy. This is a
classic enzyme induction interaction.
Why Wrong:
A - Inhibition of CYP3A4 would increase estrogen levels, not reduce efficacy.
C - Carbamazepine does not act as a receptor antagonist for estrogen.
D - Renal clearance is not the primary pathway for ethinyl estradiol metabolism.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 4
Page 3
, Q3. A patient is receiving gentamicin IV for a severe infection. Which assessment
finding indicates an adverse effect that may necessitate a change in therapy?
A. Bilateral tinnitus and dizziness
B. Elevated blood pressure
C. Increased urine output
D. Mild headache
Correct Answer: A. Bilateral tinnitus and dizziness
Rationale: Gentamicin is an aminoglycoside that can cause ototoxicity (both cochlear and
vestibular). Tinnitus and dizziness are early signs of vestibular damage. The other findings
are not typical of gentamicin toxicity.
Why Wrong:
B - Hypertension is not a common adverse effect of gentamicin.
C - Increased urine output is not an expected effect; gentamicin may cause
nephrotoxicity, which usually reduces output.
D - Headache is not a characteristic sign of gentamicin toxicity.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 82
Q4. A patient with chronic obstructive pulmonary disease (COPD) is prescribed
tiotropium. Which statement best describes the mechanism of action of this
medication?
A. Selective beta-2 agonist that relaxes bronchial smooth muscle
B. Long-acting muscarinic antagonist that inhibits bronchoconstriction
C. Corticosteroid that reduces airway inflammation
D. Leukotriene receptor antagonist that decreases mucus production
Correct Answer: B. Long-acting muscarinic antagonist that inhibits
bronchoconstriction
Rationale: Tiotropium is a long-acting muscarinic antagonist (LAMA) that blocks
acetylcholine at M3 receptors, reducing bronchoconstriction and mucus secretion. It is not
a beta-agonist, corticosteroid, or leukotriene modifier.
Why Wrong:
A - Beta-2 agonists are a different class (e.g., albuterol, salmeterol).
C - Corticosteroids act via anti-inflammatory pathways, not directly on muscarinic
receptors.
D - Leukotriene receptor antagonists are used primarily in asthma, not COPD.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 71
Q5. A patient on warfarin has an INR of 5.2. Which agent is most appropriate for
immediate reversal?
Page 4
